Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
- PMID: 33388167
- PMCID: PMC7773001
- DOI: 10.1016/j.jaci.2020.11.018
Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
Comment in
-
Reply.J Allergy Clin Immunol. 2021 Mar;147(3):1117-1118. doi: 10.1016/j.jaci.2020.11.019. Epub 2020 Dec 30. J Allergy Clin Immunol. 2021. PMID: 33388170 Free PMC article. No abstract available.
Comment on
-
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.J Allergy Clin Immunol. 2021 Feb;147(2):510-519.e5. doi: 10.1016/j.jaci.2020.09.034. Epub 2020 Oct 15. J Allergy Clin Immunol. 2021. PMID: 33068560 Free PMC article.
References
-
- Finney LJ, Glanville N, Farne H, Aniscenko J, Fenwick P, Kemp SV, et al. Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon [published online ahead of print October 15, 2020]. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2020.09.034. - DOI - PMC - PubMed
-
- Schultze A., Walker A.J., MacKenna B., Morton C.E., Bhaskaran K., Brown J.P., et al. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med. 2020;8:1106–1120. - PMC - PubMed
-
- Singanayagam A, Johnston SL. Long-term impact of inhaled corticosteroid use in asthma and chronic obstructive pulmonary disease (COPD): review of mechanisms that underlie risks [published online ahead of print January 14, 2020]. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2019.12.907. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical